龍蟠科技(603906.SH):擬與鑫豐鋰業共投建年產3萬噸氫氧化鋰/碳酸鋰項目並設立合資公司
格隆匯5月10日丨龍蟠科技(603906.SH)公佈,公司為整合上下游產業鏈資源,保障原材料的充分供應,擬與唐山鑫豐鋰業有限公司(簡稱“鑫豐鋰業”)共同投資9億元在湖北省或河北省唐山市投資開發建設年產3萬噸氫氧化鋰/碳酸鋰項目,並擬由雙方組建的合資公司實施該項目。合資公司設立時的註冊資本為人民幣2.88億元,公司擬以1.41億元人民幣出資,持有合資公司49%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.